The study conducted at SciLifeLab shows that temozolomide itself not only is cytotoxically active
against glioblastoma tumors but also against other types of brain tumors, such as medulloblastoma and metastases from other primary tumors.
Not exact matches
Bryan's group has designed a BiTE
against the EGFRvIII
tumor - specific antigen, which is expressed in a majority of
glioblastoma cases, and has performed preclinical tests to determine its efficacy
against EGFRvIII - expressing
glioblastoma.
He fought a very hard battle
against his brain
tumor (
glioblastoma multiforme) and finally succumbed to the effects of the treatment.